Abstract:BACKGROUND:To investigate the protective efficacy of miR-155 on down regulating NADPH oxidase isoform subunit A1 (NoxA1) gene expression, resulting in inhibition of VSMC migration and over proliferation and thus ameliorating the progression of arterial atherosclerosis in AS mouse model. Therefore, to further explore the regulatory effect of miR-155 on neointima formation in AS and locate potential anti-atherosclerosis target.METHODS:The mouse vascular aorta smooth muscle cell (MOVAS) was cultured and transfected with recombinant Pad2YFG adenovirus fluorescent vector with miR-155 fragment into 4 groups. Western blotting and RT-PCR were performed to identify the expression of NoxA1 under different circumstances. Fluorescence microscope was applied to observe the transfection rate of miR-155 into adenovirus. Twelve-week fatty food induced atherosclerotic ApoE-/- mouse model was established as host to accept miR-155 transfected adenovirus transplantation to observe its effect on VSMC in AS progression. Carotid and thoracic artery were extracted at 1 month after dosing. Distribution of miR-155 was quantified via expression levels of protein and RNA to detect NoxA1, Nox1, p47phox and NADPH expression. Immunohistochemistry, fluorescence imaging and other methods were performed in arteries section to compare the thickness of neointima and assess the severity of AS in each group.RESULTS:Luciferase reporter gene assay showed significant expression of miR-155 in mimic group indicating that miR-155 had target binding effect with NoxA1 gene. Western blotting and RT-PCR results both showed significantly decreased NoxA1 expression in miR-155 mimic group while increased with its inhibitor. The miR-155 distribution was observed varied at 1 month after in control, miR-155 mimic and inhibitor groups. The NoxA1, NADPH, Nox1 and pp47phox protein expression in VSMC was decreased in mimic group vs control and inhibitor groups (P<0.05); no significant difference of NADPH expression was observed in all groups. The NoxA1, Nox1 and p47phox gene expression in VSMC were both found reduced compared with those of control group at week 4 (P<0.05). Immunohistochemistry staining of artery frozen sections figured out that the thickness of neointima of carotid artery in miR-155 mimic group was significantly lower vs control and inhibitor groups (P<0.01) at week 4.CONCLUSIONS:miR-155 played an important role in NoxA1-related signaling pathway. miR-155 transfection into VSMC may have anti-inflammatory regulatory effect on NoxA1 expression in vivo and resulting in amelioration of atherosclerotic lesion in AS mouse model. In summary, miR-155 specifically plays in a negative feedback loop and demonstrates a protective role during atherosclerosis-associated VSMC proliferation and neointima formation through the miR-155-NoxA1-p47phox complex signaling pathway.

MicroRNA-497 Induces Apoptosis and Suppresses Proliferation Via the Bcl-2/Bax-Caspase9-Caspase3 Pathway and Cyclin D2 Protein in HUVECs.

MicroRNAs Expression in Ox-Ldl Treated HUVECs: MiR-365 Modulates Apoptosis and Bcl-2 Expression.

miR-92a-3p promotes ox-LDL induced-apoptosis in HUVECs via targeting SIRT6 and activating MAPK signaling pathway.

Mir-92A Inhibits Vascular Smooth Muscle Cell Apoptosis: Role of the MKK4–JNK Pathway

Effect of Mir-144-5p on the Proliferation, Migration, Invasion and Apoptosis of Human Umbilical Vein Endothelial Cells by Targeting RICTOR and Its Related Mechanisms

MicroRNA-221/222 Regulate Ox-Ldl-induced Endothelial Apoptosis Via Ets-1/p21 Inhibition

MicroRNA-495 regulates the proliferation and apoptosis of human umbilical vein endothelial cells by targeting chemokine CCL2.

Microrna-181A is Upregulated in Human Atherosclerosis Plaques and Involves in the Oxidative Stress-Induced Endothelial Cell Dysfunction Through Direct Targeting Bcl-2.

MiR-21 Suppresses Ox-Ldl-induced HUVECs Apoptosis by Targeting PDCD4.

Protection of Human Umbilical Vein Endothelial Cells Against Oxidative Stress by MicroRNA-210

MicroRNA-19b/221/222 Induces Endothelial Cell Dysfunction Via Suppression of PGC-1α in the Progression of Atherosclerosis

MiR-155 Acts As an Inhibitory Factor in Atherosclerosis-Associated Arterial Pathogenesis by Down-Regulating NoxA1 Related Signaling Pathway in ApoE-/- Mouse.

MiR-590-5p-meidated LOX-1 Upregulation Promotes Angiotensin II-induced Endothelial Cell Apoptosis

MiR-490-3p modulates the proliferation of vascular smooth muscle cells induced by ox-LDL through targeting PAPP-A.

Mir-216B-5p Regulates Proliferation and Apoptosis of Ox-Ldl-stimulated VSMCs and HUVECs Via IGF2

Mir-17 Regulates the Proliferation and Apoptosis of Endothelial Cells in Coronary Heart Disease Via Targeting Insulin-Like-growth Factor 1

Downregulation of miR-34a promotes endothelial cell growth and suppresses apoptosis in atherosclerosis by regulating Bcl-2

MicroRNA-142-3p Induces Atherosclerosis-Associated Endothelial Cell Apoptosis by Directly Targeting Rictor

MicroRNA-301a-3p increases oxidative stress, inflammation and apoptosis in ox-LDL-induced HUVECs by targeting KLF7

Effects of Microrna-124 on the Proliferation and Apoptosis of Human Umbilical Vein Endothelial Cells

MicroRNA Let-7C Inhibits Bcl-xl Expression and Regulates Ox-Ldl-induced Endothelial Apoptosis